Literature DB >> 19363452

Factors influencing fracture risk, T score, and management of osteoporosis in patients with rheumatoid arthritis in the Consortium of Rheumatology Researchers of North America (CORRONA) registry.

Kathryn A Coulson1, George Reed, Brooke E Gilliam, Joel M Kremer, Peri H Pepmueller.   

Abstract

OBJECTIVES: This study examined a wide array of clinical factors to evaluate their influence on fracture risk and T scores in women with rheumatoid arthritis (RA) and determine if women with RA who are at risk for osteoporosis (OP) are adequately treated with OP medications.
METHODS: Data from 8419 female RA patients participating in the Consortium of Rheumatology Researchers of North America registry from March 02, 2006 to August 15, 2006 was evaluated. Covariates included medication subgroups, demographic, and clinical parameters. Lumbar spine and hip T scores and fracture rates were studied in relation to the variables. Use of OP medications in patients with OP risk factors was also evaluated.
RESULTS: Postmenopausal status and higher modified health assessment questionnaire score (mHAQ) had a negative effect on lumbar spine score,while marriage, education, and body mass index had a positive effect. A similar trend was found with hip T scores. Increase in overall fracture risk correlated with postmenopausal status, mHAQ, and prednisone use, while tumor necrosis factor monotherapy was associated with decreased overall fracture risk. mHAQ was also associated with nonhip/nonspine fractures. Eighty percent of patients had at least 1 risk factor for OP, but only 32% were on OP medications. Only 54% of patients with 3 risk factors were on OP medication.
CONCLUSIONS: In RA, postmenopausal status, mHAQ, and prednisone use were associated with a higher overall fracture risk. Women with RA who were at risk for OP may have been inadequately treated with OP medications.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19363452     DOI: 10.1097/RHU.0b013e3181a5679d

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN: 1076-1608            Impact factor:   3.517


  45 in total

Review 1.  Skeletal complications of rheumatoid arthritis.

Authors:  L Heinlen; M B Humphrey
Journal:  Osteoporos Int       Date:  2017-08-04       Impact factor: 4.507

Review 2.  Use of prednisone with abiraterone acetate in metastatic castration-resistant prostate cancer.

Authors:  Richard J Auchus; Margaret K Yu; Suzanne Nguyen; Suneel D Mundle
Journal:  Oncologist       Date:  2014-10-31

3.  Effects of disease-modifying antirheumatic drugs on nonvertebral fracture risk in rheumatoid arthritis: a population-based cohort study.

Authors:  Seo Young Kim; Sebastian Schneeweiss; Jun Liu; Daniel H Solomon
Journal:  J Bone Miner Res       Date:  2012-04       Impact factor: 6.741

4.  Risk factors associated with the occurrence of hip fracture in Japanese patients with rheumatoid arthritis: a prospective observational cohort study.

Authors:  T Furuya; E Inoue; T Hosoi; A Taniguchi; S Momohara; H Yamanaka
Journal:  Osteoporos Int       Date:  2012-07-17       Impact factor: 4.507

5.  Rheumatoid arthritis and osteoporosis.

Authors:  Behzad Heidari; Mohammad Reza Hassanjani Roushan
Journal:  Caspian J Intern Med       Date:  2012

6.  Arthritis increases the risk for fractures--results from the Women's Health Initiative.

Authors:  Nicole C Wright; Jeffrey R Lisse; Brian T Walitt; Charles B Eaton; Zhao Chen
Journal:  J Rheumatol       Date:  2011-05-15       Impact factor: 4.666

7.  Vertebral fractures are increased in rheumatoid arthritis despite recent therapeutic advances: a case-control study.

Authors:  N Guañabens; J M Olmos; J L Hernández; D Cerdà; C Hidalgo Calleja; J A Martinez López; L Arboleya; F J Aguilar Del Rey; S Martinez Pardo; I Ros Vilamajó; X Suris Armangué; D Grados; C Beltrán Audera; E Suero-Rosario; I Gómez Gracia; A Salmoral Chamizo; I Martín-Esteve; H Florez; A Naranjo; S Castañeda; S Ojeda Bruno; S García Carazo; A García Vadillo; L López Vives; À Martínez-Ferrer; H Borrell Paños; P Aguado Acín; R Castellanos-Moreira; C Tebé; C Gómez-Vaquero
Journal:  Osteoporos Int       Date:  2021-01-18       Impact factor: 4.507

8.  The association between 10-year fracture risk by FRAX and osteoporotic fractures with disease activity in patients with rheumatoid arthritis.

Authors:  Ratanapha Phuan-Udom; Nittaya Lektrakul; Wanruchada Katchamart
Journal:  Clin Rheumatol       Date:  2018-07-23       Impact factor: 2.980

9.  Incidence of fractures among patients with rheumatoid arthritis: a systematic review and meta-analysis.

Authors:  S Jin; E Hsieh; L Peng; C Yu; Y Wang; C Wu; Q Wang; M Li; X Zeng
Journal:  Osteoporos Int       Date:  2018-03-15       Impact factor: 4.507

10.  Initiation of tumor necrosis factor α antagonists and risk of fractures in patients with selected rheumatic and autoimmune diseases.

Authors:  Vivian K Kawai; Carlos G Grijalva; Patrick G Arbogast; Jeffrey R Curtis; Daniel H Solomon; Elizabeth Delzell; Lang Chen; Rita Ouellet-Hellstrom; Lisa Herrinton; Liyan Liu; Edward F Mitchell; C Michael Stein; Marie R Griffin
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-07       Impact factor: 4.794

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.